AvePoint, Inc. (NASDAQ:AVPT – Get Free Report) insider Brian Brown sold 72,606 shares of AvePoint stock in a transaction on Tuesday, October 20th. The stock was sold at an average price of $15.26, for a total transaction of $1,107,967.56. Following the transaction, the insider directly owned 259,604 shares in the company, valued at $3,961,557.04. This represents a 21.86% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Brian Michael Brown also recently made the following trade(s):
- On Friday, October 16th, Brian Brown sold 3,500 shares of AvePoint stock. The stock was sold at an average price of $15.20, for a total value of $53,200.00.
- On Tuesday, October 6th, Brian Brown sold 28,894 shares of AvePoint stock. The shares were sold at an average price of $15.15, for a total transaction of $437,744.10.
- On Wednesday, September 30th, Brian Brown sold 10,000 shares of AvePoint stock. The stock was sold at an average price of $14.11, for a total value of $141,100.00.
- On Wednesday, September 23rd, Brian Brown sold 10,000 shares of AvePoint stock. The shares were sold at an average price of $13.07, for a total transaction of $130,700.00.
- On Thursday, August 27th, Brian Brown sold 60,000 shares of AvePoint stock. The stock was sold at an average price of $14.20, for a total transaction of $852,000.00.
- On Monday, August 24th, Brian Brown sold 10,000 shares of AvePoint stock. The shares were sold at an average price of $13.30, for a total transaction of $133,000.00.
- On Wednesday, July 29th, Brian Brown sold 5,176 shares of AvePoint stock. The stock was sold at an average price of $13.06, for a total value of $67,598.56.
- On Tuesday, July 28th, Brian Brown sold 4,824 shares of AvePoint stock. The stock was sold at an average price of $13.08, for a total transaction of $63,097.92.
AvePoint Stock Performance
AVPT traded up $0.49 during midday trading on Tuesday, hitting $15.23. The stock had a trading volume of 2,195,492 shares, compared to its average volume of 2,083,700. The business has a fifty day moving average of $13.65 and a 200 day moving average of $11.95. AvePoint, Inc. has a 1 year low of $8.84 and a 1 year high of $15.49. The company has a market cap of $3.22 billion, a P/E ratio of 47.60 and a beta of 1.17.
AvePoint (NASDAQ:AVPT – Get Free Report) last released its quarterly earnings data on Thursday, August 6th. The company reported $0.12 EPS for the quarter, topping the consensus estimate of $0.08 by $0.04. AvePoint had a return on equity of 15.97% and a net margin of 15.33%. The firm had revenue of $124.50 million for the quarter, compared to the consensus estimate of $121.38 million. On average, equities research analysts anticipate that AvePoint, Inc. will post 0.25 earnings per share for the current year.
Institutional Trading of AvePoint
A number of institutional investors have recently modified their holdings of AVPT. Dimensional Fund Advisors LP boosted its holdings in AvePoint by 25.7% in the first quarter. Dimensional Fund Advisors LP now owns 3,264,082 shares of the company’s stock worth $31,040,000 after acquiring an additional 666,422 shares in the last quarter. Wellington Management Group LLP boosted its position in AvePoint by 106.7% during the second quarter. Wellington Management Group LLP now owns 2,776,579 shares of the company’s stock worth $31,125,000 after purchasing an additional 1,433,299 shares in the last quarter. Healthcare of Ontario Pension Plan Trust Fund grew its position in shares of AvePoint by 25.0% in the first quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,675,587 shares of the company’s stock valued at $25,445,000 after purchasing an additional 535,015 shares during the period. Renaissance Technologies LLC boosted its stake in shares of AvePoint by 16.4% in the first quarter. Renaissance Technologies LLC now owns 2,580,153 shares of the company’s stock worth $24,537,000 after acquiring an additional 363,200 shares during the last quarter. Finally, SG Americas Securities LLC grew its stake in AvePoint by 335.2% during the 1st quarter. SG Americas Securities LLC now owns 2,391,696 shares of the company’s stock valued at $22,745,000 after acquiring an additional 1,842,124 shares in the last quarter. 44.49% of the stock is currently owned by institutional investors.
Wall Street Analysts Forecast Growth
AVPT has been the subject of a number of analyst reports. Scotiabank raised their target price on shares of AvePoint from $12.00 to $15.00 and gave the company a “sector outperform” rating in a research note on Friday, August 7th. Zacks Research downgraded shares of AvePoint from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 10th. DA Davidson reiterated a “buy” rating and issued a $18.00 price target on shares of AvePoint in a research note on Monday, July 6th. Cantor Fitzgerald reissued an “overweight” rating on shares of AvePoint in a research note on Tuesday, September 22nd. Finally, Phillip Securities raised AvePoint to a “moderate buy” rating in a research report on Monday, October 5th. Ten research analysts have rated the stock with a Buy rating and six have issued a Hold rating to the stock. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $16.25.
Read Our Latest Stock Analysis on AvePoint
About AvePoint
AvePoint, Inc (NASDAQ:AVPT) is a data management and governance software company that helps organizations protect, manage and modernize information across cloud, hybrid and on-premises environments. Its solutions are designed primarily for collaboration and productivity platforms, including Microsoft 365, SharePoint, Dynamics 365 and Salesforce.
The company’s product portfolio includes cloud backup and recovery, data migration, governance, security, compliance and administration tools.
Further Reading
- Five stocks we like better than AvePoint
- Aurora Rejects Curaleaf’s Higher Bid, But the Takeover Fight Isn’t Over
- Centrus Energy Is Building a Nuclear Fuel Powerhouse—Why Is Its Stock Struggling?
- Halliburton Gains Traction: Multiyear Upcycle Ahead
- Meta Platforms’ AI Comeback Faces an Earnings Test—And a $10 Billion Charge
Receive News & Ratings for AvePoint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AvePoint and related companies with MarketBeat.com's FREE daily email newsletter.
